Wedbush Initiates Coverage On Jade Biosciences with Outperform Rating, Announces Price Target of $17

Benzinga · 05/07 15:48
Wedbush analyst Laura Chico initiates coverage on Jade Biosciences (NASDAQ:JBIO) with a Outperform rating and announces Price Target of $17.